Cargando…
Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome
The metabolic syndrome (MetS) is a risk factor for type 2 diabetes mellitus (T2DM). However, the mechanisms underlying the transition from MetS to T2DM are unknown. Our goal was to study the potential contribution of butyrylcholinesterase (BChE) to this process. We first determined the hydrolytic ac...
Autores principales: | Shenhar-Tsarfaty, Shani, Bruck, Tal, Bennett, Estelle R, Bravman, Tsafrir, Aassayag, Einor Ben, Waiskopf, Nir, Rogowski, Ori, Bornstein, Natan, Berliner, Shlomo, Soreq, Hermona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373355/ https://www.ncbi.nlm.nih.gov/pubmed/20807286 http://dx.doi.org/10.1111/j.1582-4934.2010.01165.x |
Ejemplares similares
-
The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology(♦)
por: Podoly, Erez, et al.
Publicado: (2009) -
Leukoaraiosis Is a Chronic Atherosclerotic Disease
por: Ben-Assayag, Einor, et al.
Publicado: (2012) -
CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
por: Tene, Oren, et al.
Publicado: (2021) -
Exercise capacity and body mass index - important predictors of change in resting heart rate
por: Ehrenwald, Michal, et al.
Publicado: (2019) -
Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism
por: Brzezinski, Rafael Y., et al.
Publicado: (2020)